Continuous-infusion vindesine in refractory carcinoma of the cervix: a phase II trial.
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*; D014751:Vindesine / Q000008:administration & dosage* / Q000009:adverse effects
D014751:Vindesine